HBL - Hadasit Bio-Holdings Ltd Share Price TEL AVIV STOCK EXCHANGE
Equities
HDST
IL0010954050
Biotechnology & Medical Research
Sales 2022 | - | Sales 2023 | - | Capitalization | 74.29L 19.99L 17Cr |
---|---|---|---|---|---|
Net income 2022 | -3.1Cr -83.41L -70Cr | Net income 2023 | -2.9Cr -78.03L -65Cr | EV / Sales 2022 | - |
Net cash position 2022 | 1.29Cr 34.79L 29Cr | Net cash position 2023 | 64.6L 17.38L 15Cr | EV / Sales 2023 | - |
P/E ratio 2022 |
-0.46
x | P/E ratio 2023 |
-0.25
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 25% |
Managers | Title | Age | Since |
---|---|---|---|
Yoram Azulai
CEO | Chief Executive Officer | 63 | 20/15/20 |
Tamar Raz
CHM | Chairman | 60 | 18/14/18 |
Doron Cohen
AUD | Comptroller/Controller/Auditor | 53 | 31/15/31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Doron Nevo
BRD | Director/Board Member | 68 | 29/18/29 |
Erez Meltzer
BRD | Director/Board Member | 66 | 05/16/05 |
Orit Stav
BRD | Director/Board Member | 53 | 01/17/01 |
1st Jan change | Capi. | |
---|---|---|
+26.37% | 4.5TCr | |
-1.01% | 4.26TCr | |
+46.00% | 4.18TCr | |
-5.31% | 2.9TCr | |
+9.34% | 2.61TCr | |
-21.69% | 1.9TCr | |
+6.23% | 1.28TCr | |
+26.99% | 1.21TCr | |
-3.38% | 1.18TCr |